Delivery Order SPE2DB22D9207-SPE2DB25FH5DW
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,311.35 by the Defense Logistics Agency on July 23, 2025. The award covers the delivery of Xtandi 40 mg capsules (120 count), an oncology medication used in cancer treatment. This delivery order does not utilize a set-aside designation and is scheduled for completion by July 24, 2025, with performance taking place at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $43,113.50 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The contract employs firm fixed-price pricing and is not designated as a set-aside award. Performance will be completed by July 31, 2025, with delivery to Park Ridge, Illinois. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency (DLA) on July 22, 2025. The contract, which carries no set-aside designation, calls for the delivery of 60 tablets of Xtandi 80 mg, an oncology medication used in cancer treatment. This delivery order represents one of many pharmaceutical supply orders issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,839.02 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025, with an ultimate completion date of September 3, 2025. The delivery order is for Xtandi 40mg capsules (120 count), a prescription oncology medication, under a firm fixed-price contract type with no set-aside designation. This award represents a single...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $17,245.40 by the Defense Logistics Agency (DLA) on August 1, 2025. The contract, which carries no set-aside designation, calls for the delivery of 120 units of Xtandi 40 mg capsules, an oncology medication used in the treatment of prostate cancer. The delivery order is scheduled for completion by August 4, 2025, with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,311.35 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The delivery order carries an ultimate completion date of August 1, 2025, and was issued without set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,622.72 by the Defense Logistics Agency on August 25, 2025, for the supply of Xtandi 40 mg capsules (120-count). The contract carries no set-aside designation and is scheduled for completion by August 26, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $8.6K for 120 capsules of Xtandi 40 mg, an oncology medication. The award was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, under a firm fixed-price contract type with no set-aside designation. The contract is being funded by the Medical Supply Chain, a defense-oriented federal agency, with performance...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,622.72 by the Defense Logistics Agency (DLA) on May 30, 2025, with a completion date of June 2, 2025. The contract calls for the supply of Xtandi 40 mg capsules in quantities of 120 units. This delivery order utilizes a firm fixed-price contract type with no set-aside designation, leveraging the company's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $43,113.50 by the Defense Logistics Agency on August 20, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and no set-aside designation was used in the award. Performance will occur at the contractor's facility in Park...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB25FH5DWDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,311.35 by the Defense Logistics Agency (DLA) on August 26, 2025. The contract calls for the supply of Xtandi 40 mg capsules (120-count units), an oncology medication used in cancer treatment. This delivery order operates under a firm fixed-price structure with no set-aside designation, with an ultimate completion date of August 27, 2025. The place of performance is the contractor's facility in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. The IDC covers branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent contract performance with the Defense Logistics Agency, leveraging its woman-owned small business status to compete effectively in federal procurement markets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 8/26/25 |